Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention

Winston L. McCormick, Gail Jackson, Sarah B. Andrea, Valerie Whitehead, Tiffany L. Chargualaf, Francine Touzard-Romo

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Misclassification of Clostridioides difficile colonization as hospital-onset C. difficile infection (HO-CDI) can lead to unnecessary treatment of patients and substantial financial penalties for hospitals. We successfully implemented mandatory C. difficile PCR testing approval as a strategy to optimize testing, which was associated with a significant decline in the monthly incidence of HO-CDI rates and lowering of our standardized infection ratio to 0.77 (from 1.03) 18 months after this intervention. Approval request served as an educational opportunity to promote mindful testing and accurate diagnosis of HO-CDI.

Original languageEnglish (US)
Pages (from-to)106-109
Number of pages4
JournalInfection control and hospital epidemiology
Volume45
Issue number1
DOIs
StatePublished - Jan 10 2024

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention'. Together they form a unique fingerprint.

Cite this